Ascendis Pharma AS (STU:A71) Effective Interest Rate on Debt % : 21.03% (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Ascendis Pharma AS Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Ascendis Pharma AS's annualized positive value of Interest Expense for the quarter that ended in Mar. 2025 was €179.1 Mil. Ascendis Pharma AS's average total debt for the quarter that ended in Mar. 2025 was €851.9 Mil. Therefore, Ascendis Pharma AS's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2025 was 21.03%.

Ascendis Pharma AS Effective Interest Rate on Debt % Historical Data

The historical data trend for Ascendis Pharma AS's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Pharma AS Effective Interest Rate on Debt % Chart

Ascendis Pharma AS Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Effective Interest Rate on Debt %

Get a 7-Day Free Trial

2.98

3.97

10.00

7.65

8.73

Ascendis Pharma AS Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Effective Interest Rate on Debt %	Get a 7-Day Free Trial															47.00	11.70	13.88	-2.42	21.03

Competitive Comparison of Ascendis Pharma AS's Effective Interest Rate on Debt %

For the Biotechnology subindustry, Ascendis Pharma AS's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ascendis Pharma AS's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascendis Pharma AS's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Ascendis Pharma AS's Effective Interest Rate on Debt % falls into.

Save Embed

;

Save Embed

;

Ascendis Pharma AS Effective Interest Rate on Debt % Calculation

Ascendis Pharma AS's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2024 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (A: Dec. 2023 )	+	Total Debt (A: Dec. 2024 ))	/ count )
=	-1 * -65.504	/	( (644.265	+	856.616)	/ 2 )
=	-1 * -65.504	/	750.4405
=	8.73 %

where

	Total Debt (A: Dec. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	222.996	+	421.269
=	644.265

	Total Debt (A: Dec. 2024 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	365.08	+	491.536
=	856.616

Ascendis Pharma AS's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2025 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (Q: Dec. 2024 )	+	Total Debt (Q: Mar. 2025 ))	/ count )
=	-1 * -179.144	/	( (856.616	+	847.272)	/ 2 )
=	-1 * -179.144	/	851.944
=	21.03 %

where

	Total Debt (Q: Dec. 2024 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	365.08	+	491.536
=	856.616

	Total Debt (Q: Mar. 2025 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	357.312	+	489.96
=	847.272

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Mar. 2025) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

Ascendis Pharma AS (STU:A71) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

Ascendis Pharma AS Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Ascendis Pharma AS's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascendis Pharma AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascendis Pharma AS (STU:A71) » Definitions » Effective Interest Rate on Debt %

Comparable Companies

Traded in Other Exchanges

ASND:USA ASND:Mexico A71:Germany A1SN34:Brazil

Address

Tuborg Boulevard 12, Hellerup, DNK, DK-2900

Website

https://www.ascendispharma.com

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.

Ascendis Pharma AS Headlines

No Headlines